1369 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Shah
    Shah
  4. Sauter
    Sauter
  5. Palomba
    Palomba
  6. Goldberg
    Goldberg
  7. Halton
    Halton
  8. Brentjens
    Brentjens
  9. Chen
    Chen
  10. Moskowitz
    Moskowitz

Groups

  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)
  7. Hematologic Malignancies, Division of (327)
  8. Solid Tumor Oncology Division (324)
  9. Population Sciences Research Program (261)
  10. Biostatistics Service (257)
  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (694)
  2. Journal Article (538)
  3. Review (51)
  4. Book Section (36)
  5. Editorial (16)
  6. Research Letter (14)
  7. Miscellaneous (10)
  8. Conference Paper (4)
  9. Correspondence (4)
  10. Book Whole (1)
  11. Guidelines (1)
Groups
  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)

More Groups

People
  1. Sergio Giralt (98)
  2. Miguel-Angel Perales (77)
  3. Gunjan Shah (68)
  4. Sean Devlin (68)
  5. Craig Sauter (63)
  6. Maria Palomba (61)

More People

Years
  1. 2025 (29)
  2. 2024 (103)
  3. 2023 (92)
  4. 2022 (114)
  5. 2021 (101)
  6. 2020 (101)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Oncology Nursing Forum (117)
  3. Blood (114)
  4. Biology of Blood and Marrow Transplantation (59)
  5. Clinical Journal of Oncology Nursing (47)
  6. Annals of Surgical Oncology (36)

More Publications

Publishers
  1. American Society of Clinical Oncology (192)
  2. Elsevier Inc. (190)
  3. Oncology Nursing Society (ONS) (169)
  4. American Society of Hematology (121)
  5. Lippincott Williams & Wilkins (91)
  6. Springer (70)

More Publishers

Results (1369)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Hepatic portal venous gas from nonischemic cause: A case report
    Journal Article

    Chen, L.
    Critical Care Nursing Quarterly (2015)

    Fulltext@MSK | Save
  • The myth of 0.9% saline: Neither normal nor physiological
    Journal Article

    Chen, L.
    Critical Care Nursing Quarterly (2015)

    Fulltext@MSK | Save
  • Phase I/II trial of paclitaxel with ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin (TI-TIC) with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Journal Article

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Banked EBV-specific T-cells from HLA-partially matched normal donors to induce durable remissions of rituximab refractory EBV(+) B-cell lymphomas post hematopoietic and organ allografts
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Baroudy, K.; Boulad, F.; Khalaf, R.; Papadopoulos, E. B.; Sauter, C. S.; Szenes, V.; Suser, S.; Wasilewski, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma
    Meeting Abstract

    Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prospective study of vaginal dilator use adherence and efficacy following radiotherapy
    Journal Article

    Law, E.; Kelvin, J. F.; Thom, B.; Riedel, E.; Tom, A.; Carter, J.; Alektiar, K. M.; Goodman, K. A.
    Radiotherapy and Oncology (2015)

    Fulltext@MSK | Save